Highest Free Cash Flow Per Share in the Biotechnology Industry Detected in Shares of Biogen Idec (BIIB, AMGN, GILD, UTHR, REGN)
Below are the three companies in the Biotechnology industry with the highest free cash flow per share. FCF/share is a valuable metric signaling a company's ability to facilitate growth in the business.
Biogen Idec ranks highest with a FCF per share of $11.23. Amgen is next with a FCF per share of $10.33. Gilead Sciences ranks third highest with a FCF per share of $8.06.
United Therapeutics follows with a FCF per share of $6.39, and Regeneron Pharmaceuticals rounds out the top five with a FCF per share of $4.08.
SmarTrend is monitoring the recent change of momentum in Biogen Idec. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Biogen Idec in search of a potential trend change.
Keywords: highest free cash flow per share Biogen Idec Amgen Gilead Sciences United Therapeutics regeneron pharmaceuticals